Navigation Links
Migraines Found Linked to Nighttime Teeth Grinding & Clenching in TMJ Treatment Clinical Trial - Holistic Technologies
Date:1/29/2013

Arlington, Massachusetts (PRWEB) January 29, 2013

Clinical trial results released January 1, 2013 by Holistic Technologies show migraines were eliminated for the majority of migraine sufferers in the trial by reducing nighttime teeth grinding and clenching through nighttime biofeedback. Clinical trial participants used a wearable biofeedback headband and conditioned themselves to respond in sleep by relaxing their jaw when the biofeedback sound signaled that clenching was detected. The headband logged total clenching time, and reduction in clenching time was found clearly correlated with reduced or eliminated migraines. "These findings are consistent with the MGH brain scans that found that brain structure of migraine sufferers is often noticeably different in the part of the cortex responsible for processing sensory information from the head and face," says Lee Weinstein, CEO of Holistic Technologies.

Modern migraine theory holds that some people’s brains are more sensitive than average to certain conditions, and that for those people, those conditions bring on a migraine. Notably, the brain scan research of Dr. Nouchine Hadjikhani's at Massachusetts General Hospital found that in the migraine-sensitive brain, the part of the cortex responsible for processing sensory information from the head and face is noticeably different than in a non-migraine-sensitive brain. This is the part of the brain that gets flooded with signals from the trigeminal nerve when someone clenches their teeth in their sleep.

Until recently, almost all research aimed at developing ways to prevent migraines or cure migraines has focused on pharmaceuticals. But to consumers, ongoing consumption of pharmaceuticals represents both a contributing factor in rising healthcare
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
2. Leaders in Science Join Upcoming Celebration of the 100th Anniversary of the Oldest Science Foundation in America
3. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
4. Bacterial protein mops up viruses found in contaminated water supplies
5. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
6. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
7. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
8. Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial
9. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
10. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ... Therapy Market, 2015 - 2025" report to their ... report provides an extensive study on the marketed and ... carried out in this field for over a decade ... in Asian markets; one approved in the EU). There ...
(Date:3/3/2015)... California (PRWEB) March 03, 2015 Crown ... service company, has launched a new Life Science division ... for preclinical research. , The first products released ... isotype controls, and soon to be released in vivo ... will continue to expand their life science portfolio with ...
(Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
(Date:3/3/2015)... Liberty Corner, New Jersey (PRWEB) March 03, 2015 ... in NJ, has announced today that it has ... DE. Terms of the transaction were not ... engineering consulting services to the energy sector including ... gas, alternative energy, and fossil and nuclear power ...
Breaking Biology Technology:Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Crown Bioscience Launches Life Science Product Catalog 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... Oct. 1 Biomaxx Systems Inc. (Other,OTC: BMXSF), ... our membership,with Bioenergy Australia for 2007. BioMaxx Systems ... in Australia as a result of,our involvement with ... forum established in 1997 to promote renewable,energy solutions. ...
... Boston Scientific,Corporation (NYSE: BSX ) will webcast its ... September 30, 2007 on Friday,October 19, at 8:00 a.m. ... Tobin, President and Chief Executive,Officer, Paul LaViolette, Chief Operating ... Officer. The live webcast and archived replay of ...
... Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... abstract for TRU-015 for rheumatoid arthritis (RA), ... College of Rheumatology (ACR),Annual Scientific Meeting. This ... Association of Rheumatology Health Professionals (ARHP) Annual,Scientific ...
Cached Biology Technology:Biomaxx Systems Inc. Renews Membership With Bioenergy Australia 2Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 2Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting 2
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... In an article published in this month,s issue of ... School of Medicine (BUSM) stress the importance of physicians ... in order to make accurate health assessments for both ... existing regulatory guidelines set a standardized risk assessment of ...
... the Society,s highest honor, the 2013 Wallace H. Coulter ... David Weatherall, MD, of the University of Oxford for ... discoveries, visionary translational research leadership, and a passion for ... care for thousands throughout the developing world. ...
... An international research team led by University of Pittsburgh Cancer ... entering a state of cellular sleep, cancer drugs are more ... ,The findings, which will be published in the August 15 ... available online, are the first to show that it is ...
Cached Biology News:Study finds physicians need to better recognize use of herbal supplements while breastfeeding 2Professor Sir David Weatherall, M.D., recieves 2013 Wallace H. Coulter Award 2Professor Sir David Weatherall, M.D., recieves 2013 Wallace H. Coulter Award 3Professor Sir David Weatherall, M.D., recieves 2013 Wallace H. Coulter Award 4UPCI researchers target 'cell sleep' to lower chances of cancer recurrence 2
... instrument can be used as a fully ... Manager Software provides the means to record ... instrument. These data can then be copied ... as Microsoft Excel or Lotus 123, or ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... Oligo Microarray Kit (V2), 2 x ... characterize expression of many thousands of ... during important biological processes. Each microarray ... known ORFs from the S288C strain ...
... an intuitive, easy-to-use operating environment ... data handling, and integration with ... include data acquisition, re-analysis, custom ... both standalone and network environments. ...
Biology Products: